# LENZ Therapeutics, Inc.: Form S-1/A, filed Apr 9, 2024

- Company: [LENZ Therapeutics, Inc.](/companies/lenz.md) (CIK 1815776)
- Form: S-1/A
- Filed: 2024-04-09
- Accepted by EDGAR: Apr 8, 2024, 22:36 ET
- Period: not reported
- Accession: 0001628280-24-015318
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1815776/000162828024015318/lenz-20240408.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1815776/000162828024015318/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1815776/000162828024015318/lenz-20240408.htm

Filed Apr 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-015318. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.